Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

NCT02888743 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

110

Enrollment

NIH

Sponsor class

Conditions

Metastatic Colorectal Carcinoma
Metastatic Lung Non-Small Cell Carcinoma
Stage IV Colorectal Cancer AJCC v7
Stage IV Lung Non-Small Cell Cancer AJCC v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7

Interventions

BIOLOGICAL: Durvalumab
RADIATION: Radiation Therapy
BIOLOGICAL: Tremelimumab

Sponsor

National Cancer Institute (NCI)